Ray L.

Ray L. has a vast and extensive work experience in the field of protein sciences. Ray currently holds the position of Senior Director of Protein Sciences at Nutcracker Therapeutics, starting in February 2022. Prior to this, they worked as the Director of Protein Sciences at Gilead Sciences from October 2021 to January 2022.

Before joining Gilead Sciences, Ray L. served as the Head of Protein Sciences, Biotherapeutics at Denali Therapeutics from September 2020 to October 2021. Ray also worked as a Principal Scientist at Denali Therapeutics from August 2018 to September 2020.

Furthermore, Ray L. gained experience at Amgen, where they served as the Protein Purification Lead, Biologics Discovery from an unspecified date in 2015 to 2018. Prior to Amgen, they worked at Shire Pharmaceuticals as a Senior Scientist in Discovery Therapeutics until September 2015.

Ray L. also worked as a Principal Scientist at Blue Sky BioServices from an unspecified date in 2011 to 2012. Before that, they held the position of Director, Protein Expression, Purification, and Characterization Facility at the University of South Florida in 2010-2011.

In the early stages of their career, Ray L. worked as a Staff Scientist at Sanford-Burnham Medical Research Institute from 2005 to 2009. Prior to this, they were a Postdoctoral Research Fellow at the same institute from 2002 to 2005. Ray also served as a Postdoctoral Research Fellow at The Scripps Research Institute from 2001 to 2002.

Overall, Ray L. has a diverse and impressive work history in various scientific roles, primarily focusing on protein sciences.

Ray L. pursued a Bachelor's Degree in Biochemistry (Honors) from The University of Manchester. Later, they attended the University of Cambridge where they completed their Doctor of Philosophy (Ph.D.) in Biochemistry.